Masonic Cancer Center, University of Minnesota (Site 116) — Minneapolis, Minnesota

Masonic Cancer Center, University of Minnesota (Site 116) is a clinical research site located in Minneapolis, Minnesota, United States 55455.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Masonic Cancer Center, University of Minnesota (Site 116) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Sponsors: J-Pharma Co., Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Masonic Cancer Center, University of Minnesota (Site 116)?

Masonic Cancer Center, University of Minnesota (Site 116) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Masonic Cancer Center, University of Minnesota (Site 116) conducted?

Masonic Cancer Center, University of Minnesota (Site 116) has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Is Masonic Cancer Center, University of Minnesota (Site 116) accredited by Crixeo Health?

Masonic Cancer Center, University of Minnesota (Site 116) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Masonic Cancer Center, University of Minnesota (Site 116)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.